Unlocking the Potential of Genetic Medicines
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
Company Details
- Employees
- 52
- Founded
- -
- Address
- 3675 Market Street,
- in****@****otx.com
- Industry
- Biotechnology
- Website
- arobiotx.com
- Keywords
- Drug Discovery, Drug Development, Licensing, Drug Delivery, siRNA, Immunology, Bispecifics, Protein Conjugation, Protein Therapeutics, Oligonucleotide Delivery, Protein Engineering, Targeted Nanoparticles, Genetic Medicine, Tissue-specific Targeting, Biotechnology.
- HQ
- Philadelphia, Pennsylvania
Aro Biotherapeutics Questions
Aro Biotherapeutics's website is arobiotx.com
Aro Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/aro-biotherapeutics
Aro Biotherapeutics has
52 employees.
View email and phone details for 52
employees at Aro Biotherapeutics.
Aro Biotherapeutics's industry is
Biotechnology
Aro Biotherapeutics's top competitors are
Century Therapeutics, Inc,
Interius Biotherapeutics,
Passage Bio,
Verismo Therapeutics,
Switch Therapeutics,
Cabaletta Bio,
Vivodyne,
Spark Therapeutics, Inc.,
Swanbio Therapeutics,
Carisma Therapeutics.
Aro Biotherapeutics's support email address is info@arobiotx.com
Aro Biotherapeutics's categories are Biotechnology
Aro Biotherapeutics's founding year is 2018
